“We come to work and do things nobody has done before”

QB3 Alumni, Loren Perelman, PhD
Director of Quality and Analytics @BoltThreads

Leadership in Biopharma: A Conversation with John Milligan, CEO of Gilead Sciences

Gilead is known worldwide for its antiviral therapies. May 11, Threshold Pharmaceuticals CEO Barry Selick, a former UCSF postdoc, will engage Gilead's CEO John Milligan—another former UCSF postdoc—in a public Q&A about his career and leadership.

Join the Event

Get Inspired in Medtech

Register for the Rosenman Symposium, our annual medtech conference, scheduled for June 21, 2017.

Learn more


Incubators at QB3

Find lab space at one of our five incubators close to UC faculty and resources.

Learn More

JOBS

Your career in the life sciences starts here. Check current job listings at startups in the Bay Area. 

LEARN MORE

QB3 ECOSYSTEM

Tap into the QB3 network of resources, funding, and core facilities, across three UC campuses.

LEARN MORE

Impact in Numbers

Partner with us to gain access to the most innovative life science startups, and make your next big strategic investment.

 
$600 M/yr in funding

$600 M/yr in
funding

$161 M/yr in revenue

$161 M/yr in
revenue

500+ early-stage companies

500+ early-stage
companies

400+ companies in QB3 Startup in a Box

400+ companies
in QB3 Startup in a Box

Leading innovative industry partners

Leading innovative
industry partners

 

QB3 STARTUPS IN THE NEWS